{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:14:29Z","timestamp":1784816069907,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jpsychires.2024.09.003","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:17:48Z","timestamp":1726186668000},"page":"141-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Effective action of silymarin against ketamine-induced schizophrenia in male mice: Insight into the biochemical and molecular mechanisms of action"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3569-3575","authenticated-orcid":false,"given":"Benneth","family":"Ben-Azu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2440-3627","authenticated-orcid":false,"given":"Aliance R.","family":"Fokoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olajide S.","family":"Annafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun G.","family":"Adebayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-4845","authenticated-orcid":false,"given":"Elisabetta C.","family":"del Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Okuchukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbemileke J.","family":"Aregbesola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akpor-esiri C.","family":"Ejenavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Isiwele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arausi J.","family":"Efezino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifelunwa D.","family":"Okpu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2024.09.003_bib1","first-page":"1","article-title":"Ameliorative effect of oregano (Origanum vulgare) versus silymarin in experimentally induced hepatic encephalopathy","author":"Abdelghffar","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.22270\/jddt.v10i1.3865","article-title":"Psychotic disorders, definition, sign and symptoms, antipsychotic drugs, mechanism of action, pharmacokinetics & pharmacodynamics with side effects & adverse drug reactions: updated systematic review article","volume":"10","author":"Bangwal","year":"2020","journal-title":"J. Drug Deliv. Therapeut."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.48129\/kjs.v48i2.9264","article-title":"Role of neurotransmitters in schizophrenia: a comprehensive study","volume":"48","author":"Bansal","year":"2021","journal-title":"Kuwait J. Sci."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib4","series-title":"Cognizance of Schizophrenia: A Profound Insight into the Psyche","first-page":"33","article-title":"Understanding the chemical interactions in the brain of schizophrenia patients","author":"Bansal","year":"2023"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2020.4693","article-title":"Association of ketamine with psychiatric symptoms and implications for its therapeutic use and for understanding schizophrenia: a systematic review and meta-analysis","volume":"3","author":"Beck","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.scog.2023.100281","article-title":"Spatial and non-spatial feature binding impairments in visual working memory in schizophrenia","volume":"32","author":"Belekou","year":"2023","journal-title":"Schizophrenia Research. Cognition"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.brainresbull.2018.03.006","article-title":"Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice","volume":"139","author":"Ben-Azu","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0043-119127","article-title":"Morin pretreatment attenuates schizophrenia-like behaviors in experimental animal models","volume":"68","author":"Ben-Azu","year":"2018","journal-title":"Drug Res."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib9","first-page":"1745","volume":"vol. 43","author":"Ben-Azu","year":"2018"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainresbull.2018.02.007","article-title":"Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways","volume":"139","author":"Ben-Azu","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib11","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1007\/s11011-022-01075-5","article-title":"Taurine, an essential \u03b2-amino acid insulates against ketamine-induced experimental psychosis by enhancement of cholinergic neurotransmission, inhibition of oxidative\/nitrergic imbalances, and suppression of COX-2\/iNOS immunoreactions in mice","volume":"37","author":"Ben-Azu","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s11064-022-03808-5","article-title":"Reversal and preventive pleiotropic mechanisms involved in the antipsychotic-like effect of taurine, an essential \u03b2-amino acid in ketamine-induced experimental schizophrenia in mice","volume":"48","author":"Ben-Azu","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.dscb.2024.100122","article-title":"Containment of neuroimmune challenge by diosgenin confers amelioration of neurochemical and neurotrophic dysfunctions in ketamine-induced schizophrenia in mice","volume":"13","author":"Ben-Azu","year":"2024","journal-title":"Brain Disorders"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176791","article-title":"Psychopharmacological interaction of alcohol and posttraumatic stress disorder: effective action of naringin","volume":"978","author":"Ben-Azu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ibneur.2023.12.008","article-title":"Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: involvement of oxidative stress and cholinergic transmission","volume":"16","author":"Ben-Azu","year":"2024","journal-title":"IBRO neuroscience Rep."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.alcohol.2024.07.009","article-title":"Alcohol-exacerbates post-traumatic stress psychiatric behavior and its neuropathological sequalae in experimental mice: preventive effects of morin","author":"Ben-Azu","year":"2024","journal-title":"Alcohol (Fayetteville, N.Y.), S0741-8329(24)00111-3"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Neuroscience and Biobehavioral Reviews Oxidative stress in schizophrenia : an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.jpsychires.2024.09.003_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/schbul\/sbw146","article-title":"Heritability of neuropsychological measures in schizophrenia and nonpsychiatric populations: a systematic review and meta-analysis","volume":"43","author":"Blokland","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psychres.2017.03.038","article-title":"Oxidative and nitrosative stress biomarkers in chronic schizophrenia","volume":"253","author":"Boll","year":"2017","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/cns.12175","article-title":"Neuroprotective potential of silymarin against CNS disorders : insight into the pathways and molecular mechanisms of action silymarin in neurodegenerative disorders","volume":"19","author":"Borah","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"Pt 3","key":"10.1016\/j.jpsychires.2024.09.003_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.foodres.2017.07.017","article-title":"The silymarin composition\u2026 and why does it matter?","volume":"100","author":"Chambers","year":"2017","journal-title":"Food Res. Int."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109868","article-title":"Progress in Neuropsychopharmacology & Biological Psychiatry Clinical implications of oxidative stress in schizophrenia : acute relapse and chronic stable phase","volume":"99","author":"Chien","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib22","series-title":"Polyphenols in the Prevention of Past , Present and Future, Polyphenols in Human Health and Disease","author":"Colitis","year":"2014"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173949","article-title":"Sex influences in the preventive effects of peripubertal supplementation with N-3 polyunsaturated fatty acids in mice exposed to the two-hit model of schizophrenia","volume":"897","author":"da Costa","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpsychires.2016.09.017","article-title":"Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs","volume":"84","author":"da Silva Ara\u00fajo","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib25","article-title":"Diagnostic and statistical manual of mental disorders","author":"Del Barrio","year":"2016","journal-title":"Curated Ref. Collect. Neurosci. Biobehav. Psychol"},{"issue":"2","key":"10.1016\/j.jpsychires.2024.09.003_bib27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/schbul\/sbaa127","article-title":"Baseline cortical thickness reductions in clinical high risk for psychosis: brain regions associated with conversion to psychosis versus non-conversion as assessed at one-year follow-up in the Shanghai-At-Risk-for-Psychosis (SHARP) study","volume":"47","author":"del Re","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2021.100037","article-title":"Anterior-posterior axis of hippocampal subfields across psychoses: a B-SNIP study","volume":"5","author":"del Re","year":"2021","journal-title":"Biomarkers Neuropsychiatry"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2023.03.029","article-title":"Characterization of childhood trauma, hippocampal mediation and Cannabis use in a large dataset of psychosis and non-psychosis individuals","volume":"255","author":"del Re","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2024.09.003_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12031-022-02084-w","article-title":"Normalization of HPA Axis, cholinergic neurotransmission, and inhibiting brain oxidative and inflammatory dynamics are associated with the adaptogenic-like effect of rutin against psychosocial defeat stress","volume":"73","author":"Emudainohwo","year":"2023","journal-title":"J. Mol. Neurosci.: MN"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12031-022-02077-9","article-title":"Lipopolysaccharide exacerbates ketamine-induced psychotic-like behavior, oxidative stress, and neuroinflammation in mice: ameliorative effect of diosmin","volume":"73","author":"Eneni","year":"2023","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8881770","article-title":"Oxidative stress-related mechanisms in schizophrenia pathogenesis and new treatment perspectives","volume":"2021","author":"Ermakov","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib36","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s11011-021-00825-1","article-title":"The antioxidant and neuroprotective effects of the Psychotria camptopus Verd. Hook. (Rubiaceae) stem bark methanol extract contributes to its antiepileptogenic activity against pentylenetetrazol kindling in male Wistar rats","volume":"36","author":"Fokoua","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib37","article-title":"Hepatoprotective effect of silymarin (Silybum marianum) on hepatotoxicity induced by acetaminophen in spontaneously hypertensive rats","volume":"2015","author":"Freitag","year":"2015","journal-title":"Evid. base Compl. Alternative Med.: eCAM"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib38","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib39","article-title":"Neuroprotective effects of silymarin in 3-nitropropionic acid-induced neurotoxicity in male mice: improving behavioral deficits by attenuating oxidative stress and neuroinflammation","author":"Haddadi","year":"2023","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: an update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.brainresbull.2021.10.007","article-title":"Prevention and reversal of ketamine-induced experimental psychosis in mice by the neuroactive flavonoid, hesperidin: the role of oxidative and cholinergic mechanisms","volume":"177","author":"Ishola","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neulet.2016.06.008","article-title":"Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice","volume":"629","author":"Jin","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib43","article-title":"Schizophrenia","volume":"1","author":"Kahn","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib44","series-title":"Current Topics in Behavioral Neurosciences","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/7854_2010_42","article-title":"Neurocognition in schizophrenia","author":"Kalkstein","year":"2010"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib45","first-page":"1","article-title":"IL-4, TGF-\u03b2, NF-\u03baB and MPO levels in patients with treatment resistant schizophrenia","volume":"27","author":"Kartalci","year":"2016","journal-title":"T\u00fcrk Psikiyatri Derg."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/vms3.641","article-title":"A review on the mechanisms of the effect of silymarin in milk thistle (Silybum marianum) on some laboratory animals","volume":"8","author":"Khazaei","year":"2022","journal-title":"Vet. Med. Sci."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib47","series-title":"Handbook of Behavioral Neuroscience","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-800981-9.00005-5","article-title":"Animal models of psychotic disorders : dimensional approach modeling negative symptoms","author":"Kirby","year":"2016"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib48","series-title":"Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders","first-page":"843","article-title":"The neurobiology of schizophrenia","author":"Konopaske","year":"2022"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/life13040999","article-title":"Phytochemicals: a promising alternative for the prevention of Alzheimer's disease","volume":"13","author":"Koul","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112832","article-title":"Association of circulating BDNF levels with BDNF rs6265 polymorphism in schizophrenia","volume":"394","author":"kumar","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-022-00402-y","article-title":"Neuroprotective effect of hesperidin and its combination with coenzyme Q10 on an animal model of ketamine-induced psychosis: behavioral changes, mitochondrial dysfunctions, and oxidative stress","volume":"8","author":"Kumar","year":"2022","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116305","article-title":"The global burden of schizophrenia and the impact of urbanization during 1990 \u2013 2019 : an analysis of the global burden of disease study 2019","volume":"232","author":"Li","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib53","article-title":"Neurobiology of schizophrenia: a comprehensive review","volume":"14","author":"Luvsannyam","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20693","article-title":"Dopamine and glutamate in schizophrenia: biology, symptoms and treatment","volume":"19","author":"McCutcheon","year":"2020","journal-title":"World Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/eip.12859","article-title":"Role of inflammation in the pathogenesis of schizophrenia: a review of the evidence, proposed mechanisms and implications for treatment","volume":"14","author":"Mongan","year":"2020","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib57","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1177\/0269881113503506","article-title":"Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathways","volume":"27","author":"Monte","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib59","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.euroneuro.2013.09.011","article-title":"Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans","volume":"24","author":"Neill","year":"2014","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.jpsychires.2024.09.003_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5497\/wjp.v11.i3.27","article-title":"Antidepressant-like potential of silymarin and silymarin-sertraline combination in mice: highlighting effects on behaviour, oxidative stress, and neuroinflammation","volume":"11","author":"Onaolapo","year":"2022","journal-title":"World J. Pharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2024.09.003_bib61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4306\/pi.2014.11.3.281","article-title":"Distinctive clinical correlates of psychotic major depression: the CRESCEND study","volume":"11","author":"Park","year":"2014","journal-title":"Psychiatry investigation"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib62","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jconrel.2021.05.046","article-title":"Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier","volume":"335","author":"Pathan","year":"2021","journal-title":"J. Contr. Release: J. Controlled Release Soc."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib64","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/ejn.15845","article-title":"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network","volume":"57","author":"Qin","year":"2023","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.jpsychires.2024.09.003_bib65","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1186\/s40064-016-3267-1","article-title":"Natural flavonoids silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs","volume":"5","author":"Ravikumar Reddy","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2022.103261","article-title":"Neurohemodynamic correlates of BDNF gene expression in schizophrenia patients with working memory deficits: a functional MRI study","volume":"77","author":"Selvaraj","year":"2022","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2020.00613","article-title":"Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia","volume":"11","author":"Sonnenschein","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.schres.2016.10.011","article-title":"Schizophrenia is associated with a pattern of spatial working memory deficits consistent with cortical disinhibition","volume":"181","author":"Starc","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.biopha.2018.03.140","article-title":"Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases","volume":"102","author":"Taleb","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.jpsychires.2024.09.003_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0269881117742666","article-title":"Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice","volume":"32","author":"Thakare","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2024.09.003_bib71","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","article-title":"Hepatoprotective effect of silymarin","volume":"6","author":"Vargas-Mendoza","year":"2014","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules27165327","article-title":"Mechanistic insights into the pharmacological significance of silymarin","volume":"27","author":"Wadhwa","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpsychires.2024.09.003_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5981353","article-title":"Silibinin ameliorates formaldehyde-induced cognitive impairment by inhibiting oxidative stress","volume":"2022","author":"Wei","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.659678","article-title":"Silybin alleviates experimental autoimmune encephalomyelitis by suppressing dendritic cell activation and Th17 cell differentiation","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jpsychires.2024.09.003_bib75","doi-asserted-by":"crossref","DOI":"10.1515\/jbcpp-2018-0109","article-title":"The effect of silymarin supplementation on cognitive impairment induced by diabetes in rats","volume":"30","author":"Y\u00f6n","year":"2019","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.jpsychires.2024.09.003_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104595","article-title":"Interaction between TNF-\u03b1 and oxidative stress status in first-episode drug-na\u00efve schizophrenia","volume":"114","author":"Zhu","year":"2020","journal-title":"Psychoneuroendocrinology"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624005247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624005247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T17:20:52Z","timestamp":1730136052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395624005247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":72,"alternative-id":["S0022395624005247"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.09.003","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective action of silymarin against ketamine-induced schizophrenia in male mice: Insight into the biochemical and molecular mechanisms of action","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}